Maruti, Honda, Mahindra and others stops manufacturing due to Covid19 outbreak

▴ Maruti Honda Mahindra and others stops manufacturing due to Covid19 outbreak
All automakers stops production til 31st March

Maruti Suzuki India (MSI), Mahindra & Mahindra and Honda Cars, recentlyannounced suspension of manufacturing activities across plants in the wake of the coronavirus outbreak in the country.

 MSI stopped production at its Gurgaon and Manesar plants with immediate effect, while Honda Cars India Ltd (HCIL) to end manufacturing at its two plants in the country till 31 March.

Meanwhile Mahindra & Mahindra (M&M) announced to suspend production at its manufacturing plants in Maharashtra.

Automaker Fiat also suspends  production in the country till the end of this month.

From other automobile companies,Hero MotoCorp and Honda Motorcycle and Scooter India (HMSI) suspended production across their manufacturing plants.

HMSI said, "The company will shut production and office operations at its facilities in Gurugram and Manesar (Haryana) with immediate effect till further notice."

The company's research and development centre at Rohtak will also remain closed, it added.

The duration of this shutdown will depend upon government policy, MSI said.

The company's two plants in Haryana—Manesar and Gurgaon—churn out 15.5 lakh vehicles per annum.

HCIL said production operations at  manufacturing plants in Greater Noida (Uttar Pradesh) and Tapukara (Rajasthan) will suspended from 23-31 March.

The company said its intention is to restart production on 1 April, however, this will be dependent upon advice from the government, health authorities, and market and supply conditions.

M&M said it has suspended manufacturing operations at its Nagpur plant with immediate effect and will also halt production at Chakan (Pune) and Kandivali (Mumbai) from Monday.

None of the company plants is working on Sunday also, M&M added.

"We are carefully monitoring the rapidly evolving COVID-19 pandemic and will continue to take swift and appropriate action on other plants in Maharashtra and across the nation," the company said.

Meanwhile, all company offices across the country have been ordered to work from home, it added.

Similarly, automaker Fiat Chrysler Automobiles (FCA) together with Fiat India Automobiles Private Limited (FIAPL), FCA's joint venture manufacturing facility in Ranjangaon, said the temporary suspension is in response to the increasing prevalence of positive COVID-19 cases in Maharashtra and particularly in Pune.

"There will be no retrenchment of any plant employees as a result of the plant closure and all will continue to receive their salaries during this closure period", the company said.

MG Motor India said production at its Halol (Gujarat) plant is closed till 25 March.

Market leader Hero MotoCorp said it has suspended production until 31 March.

"With the safety and well-being of its employees as top priority in view of the escalating COVID-19 situation, the company has decided to halt operations at all its global manufacturing facilities—including in India, Colombia and Bangladesh—and the Global Parts Centre (GPC) at Neemrana with immediate effect until 31 March, 2020," Hero MotoCorp said.

Employees at all the other functions and locations, including the Centre of Innovation and Technology (CIT) at Jaipur, will continue to work from home, except for those whose physical presence is necessary to run the day-to-day essential services, it added.

Similarly, Honda Motorcycle and Scooter India (HMSI) said it has suspended operations across its four manufacturing plants in the country with immediate effect.

"The well-being of employees and all stakeholders being the top priority, the company has temporarily announced shutdown of operations across all its four manufacturing plants with immediate effect till further notice," HMSI

Story Input :Firstpost

Tags : #Maruti #Honda #Mahinda #Fiat #Heromotocorp #Hmsi #MGmotor

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Advancing Cancer Care: AIIMS Bhopal’s Workshop on Biomarker Interpretation in Breast CancerApril 15, 2024
10 Powerful Benefits to Diversify Healthcare Advertising ChannelsApril 15, 2024
Understanding Hospital Sink Contamination: Challenges in Fighting Multidrug-Resistant BacteriaApril 15, 2024
Rajasthan’s Swine Flu Situation: Health Department Observes DeclineApril 15, 2024
Is Your Doctor’s Prescription Incomplete ? Insights from Recent ICMR Study Suggests So!April 13, 2024
Ministry of Health Dispels Misinformation on Medicine Price Surge from April 1April 13, 2024
India’s First Indigenous CAR T-Cell Therapy Launched By President Droupadi Murmu: A New Hope in Cancer TreatmentApril 12, 2024
Investigation Launched After Cataract Surgery Patients Experience Side-Effects in IndoreApril 12, 2024
The Reality of Protein Supplements in India: Mislabeling, Toxins, and Quality ChallengesApril 12, 2024
A Majority Of People Are Piling Up Weight Despite Adhering To A Healthy Lifestyle, Opt For These Vital Tests: ExpertsApril 11, 2024
Fighting Tuberculosis: IHLD and Krafton India Join Forces for Active Case DetectionApril 11, 2024
ICMR Study Reveals Blood Pressure Monitoring Gaps in IndiaApril 11, 2024
Innovative Procedure at KGMU Saves Man Impaled by Iron Rod: Beating Heart Surgery SuccessApril 11, 2024
Heart-Healthy Choices: How Salt Substitutes Can Prolong Your LifeApril 11, 2024
Unveiling Cancer Patterns in Families of Men with Fertility ChallengesApril 11, 2024
10 secrets of Successful Healthcare Branding and advertising campaignsApril 10, 2024
Global Hepatitis Crisis: India Ranks Second in Cases – WHO Report 2024April 10, 2024
Accelerated Ageing and Cancer Risk: New Perspectives from AACR 2024April 10, 2024
Man Hospitalized with Rare Bacterial Infection After Rat Bite: What You Need to KnowApril 10, 2024
Enhanced rock weathering results in higher crop yields and improved crop healthApril 09, 2024